HTT and nervous system disorder: Therefore, non-allele-specific therapies by which expression of both mutant and wild-type forms of the HTT protein are lowered are also being tested, the rationale being that the benefits of lowering mHTT in the context of a fatal, debilitating neurological disease will likely outweigh any negative effects of transiently lowering expression of the wild-type protein.